2019 Outstanding Physician Clinician in Diabetes Award
David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE is the recipient of the 2019 Outstanding Physician Clinician in Diabetes Award. Sponsored by Janssen Pharmaceutical Companies of Johnson & Johnson, this award is presented to an individual to reward and honor meritorious contributions to diabetes clinical practice.
Dr. Klonoff is Medical Director of the Diabetes Research Institute at Mills-Peninsula Medical Center and a Clinical Professor of Medicine at UCSF. He practices endocrinology in Burlingame, California. In 1998 Dr. Klonoff coined the term “diabetes technology” when the focus of diabetes treatment was on biology. He has been a leader in diabetes hardware, software, digital health, and device cybersecurity. Dr. Klonoff has received an FDA Director’s Special Citation Award for his work in diabetes technology. In 2000 he founded Diabetes Technology Society, a non-profit organization promoting development and use of technology for patients with diabetes. Dr. Klonoff has spoken to the US Congressional Diabetes Caucus, participated in the White House Health and Cybersecurity Roundtable, and spoken at the European Parliament. He has been a Principal Investigator in over 110 clinical trials of devices and drugs and has published over 200 articles in PubMed-indexed journals.
Dr. Klonoff is founding editor-in-chief of Journal of Diabetes Science and Technology. He has chaired three diabetes device cybersecurity standard steering committees, the Diabetes Technology Society Surveillance Program for Cleared Blood Glucose Monitors, the Endocrine Society CGM Clinical Guidelines Committee, and the CLSI CGM Performance Metrics Committee.
Please join us in celebrating David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE for outstanding accomplishments in diabetes care.